An interventional study of Near vision glasses for presbyopia correction in Presbyopia Correction, Visual Impairment and Blindness (Excl Colour Blindness) and Repayment Behaviour, sponsored by Dot Glasses Kenya. Not yet recruiting. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2025-01-14.
Sponsored by Dot Glasses Kenya · Not applicable, Interventional, and Other
With age, people lose the ability to see things that are near them clearly. This is known as presbyopia. Although this is a normal ageing process, it can be corrected with near vision eyeglasses - colloquially known as reading glasses - and people should not have to "put up with" poor near vision. By improving the ability to see things that are up-close, near vision eyeglasses allow people to perform tasks with greater ease. This improves their quality of life, and increases their productivity and income. DOT Glasses provides people in East Africa with a range of eyeglasses, including those to improve near vision.
In addition, products sold to communities through loans repaid at regular intervals (known as asset financing), allow people in underserved communities to harness electricity through solar products and to own electronic devices, such as mobile phones. This also improves their quality of life, and increases their productivity and income. Sun King is one of the leading providers of solar products through loans in Kenya.
This study will gather evidence and insights from existing Sun King customers with poor near vision in Busia, Siaya, Vihiga and Kakamega. The investigators will explore how much giving people glasses to improve their near vision impacts their ability to make repayments, their incomes and livelihoods, and their overall quality of life. It will also be studied how the glasses affect participants usage of the solar device or mobile phone.
Aim:
To identify the impact on SHS and mobile phone use, repayment behaviour and income, of providing near vision glasses (NVGs) to customers with near vision impairment (NVI).
Primary objective:
● To determine the effect of presbyopia correction via NVGs, on SHS and mobile phone repayment behaviour:
Secondary objectives:
POPULATION Sun King SHS or mobile phone (purchased on credit) users, aged 40 years or above, with presbyopia, who purchased their product at least 3 months ago and have at least 6 months of repayments remaining.
INTERVENTION Provision of NVGs for presbyopia correction.
CONTROL Delayed provision of NVGs, presbyopia correction.
TIME FRAME 6 months
HYPOTHESIS Correcting presbyopia with NVGs improves the rate of SHS or mobile phone repayments made on time.
NULL HYPOTHESIS Correcting presbyopia with NVGs does not change the rate of repayments made or the proportion of time the participants have their system enabled.
STUDY DESIGN Randomised Control Trial.
STUDY AREA The study area includes rural, peri-urban and urban communities in Busia, Siaya, Vihiga and Kakamega in Western Kenya
SAMPLE SIZE DETERMINATION Mean solar product repayments to Sun King for the entry level category, products priced between KES 7,000 and 30,000, are KES 405 per month. To be able to identify a 10% difference in repayments between the groups, with a two-sided significance level of p=0.05 and power of 90%, a sample size of 461 per group is required. The investigators will screen 1,480 people, of which it is expected 1085 to meet the enrolment criteria. 543 will be randomly allocated to join the experimental group who will be provided their glasses at the start of the study and 543 will be randomly allocated to join the control group who will receive their glasses at the end of the study. The investigators expect the attrition rate to be similar across both groups, at \~15%. This will give us a final sample per group of at least 461.
SAMPLING PROCEDURES A software application will be used to randomly select whether participants go into the study or control group. The application will randomly select from the participants list, then randomly invite participants on one of two days per locality for the screening, provision of NVGs and baseline surveys. The day attended will determine participants' allocation to the glasses or control groups.
All participants on day two will receive glasses and all on day one do not (control). Neither group will be informed beforehand if they are receiving glasses or not; they will only be invited for a screening.
RECRUITMENT OF STUDY SUBJECTS
Sun King will call existing customers with the following criteria to invite them to participate in the study:
If they are willing to participate they will be asked if they have a pair of NVGs. If they do not have a pair, they will then be added to the initial participant list. If they have a pair, they will be excluded from selection. The selected study participants will be asked to complete and sign a consent form prior to the initial assessment and then randomly allocated to the experimental or control group.
Participants will receive compensation for travel expenses of 300 KSH
Data collection methodology
The data collection will be primarily quantitative. The data will be collected through:
RESEARCH STAFF TRAINING
DOT Glasses take the RAs through a 1-day training. The curriculum will cover:
DATA COLLECTION
i. Test presenting Near Visual Acuity. ii. Assess required near correction lens power (dioptres). iii. Retest corrected NVA. iv. Refer to a specialist if:
a. Intervention group: i. At 3 months participants will have an over the phone follow up to ask whether or not they are using the glasses.
ii. At 6 months follow up questionnaire and eye screening in person. b. Control group: i. At 6 months followed up questionnaire, eye screening and distribution of glasses.
COLLECTED DATA An overview of key question areas in the study tools is outlined below. Participant demographics
Credit Questions
Solar questions
Income and livelihoods
Vision-related quality of life assessment
● focusing on how their poor near vision has affected their daily lives.
At the end line, participants will be asked questions that measure their use of NVGs and the impact they have made on the above categories. With the control group getting a similar questions set.
144 studies on the registry are indexed under Blindness; 33 are open to participants now.
This study's planned enrollment of 1,085 is above the median of 37 across 101 interventional studies indexed under Blindness.
Browse Blindness studies →This is the only study on the registry with Dot Glasses Kenya as lead sponsor.
Compared within Blindness, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Vision Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Provision of NVGs for presbyopia correction at baseline for study duration
Other: Near vision glasses for presbyopia correction
Participants in the no intervention control group will be followed over the same period as the near vision glasses intervention group but will have no near vision glasses provided (glasses will be provided at the end of the study).
Provision of near vision glasses for presbyopia correction to individuals who did not previously have glasses and have correctable presbyopia
Repayment behaviour - time
The proportion of total payments made on time
Time frame: Measured at baseline and end of the study (6 months)
Product usage
The proportion of time solar home systems and mobile phones products are enabled
Time frame: Measured at baseline and end of the study (6 months)
Repayment behaviour - percentage revenue
Percentage of expected revenue collected by the solar home system provider within a six month time period
Time frame: Measured at baseline and end of the study (6 months)
Vision related quality of life
Changes in perceived vision related quality of life assessed by questionnaire. Vision related quality of life will be assessed by 9 questions relating to how much difficulty the participant has in performing day to day tasks relating to their eyesight. Questions are answered on a scale from no difficulty at all to having to unable to perform the task due to eyesight issues.
Time frame: Measured at baseline and end of the study (6 months)
Income
Changes in self-reported income assessed by questionnaire. Participants will be asked how they generate an income and for each income source they will be asked how much they make per month from the income source (in KES).
Time frame: Measured at baseline and end of the study (6 months)
Livelihood
Changes in livelihood (source of income) assessed by questionnaire. Participants will be asked what there source of income is with the option to select multiple sources of income.
Time frame: Measured at baseline and end of the study (6 months)
No study locations are listed for this record.
Plan to share: Undecided — Anonymised IPD data may be shared with other researchers for future research.
Start is estimated for Feb 2025; primary completion for Aug 2025, 6 months later.
Of 36 interventional studies with no phase under Blindness, half reached primary completion within 57 months of starting (the median), counting those still running; a quarter within 19. This study's planned 6 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.